Abevmy 400 mg Injection
  1. Home
  2. Pharma Products
  3. Mylan Pharmaceuticals Pvt Ltd
  4. Abevmy 400 mg Injection

Abevmy 400 mg Injection

Abevmy 400 mg Injection contains bevacizumab 400 mg, a monoclonal antibody used as targeted cancer therapy. It is used for cancers including colorectal, non-small-cell lung, kidney, ovarian, cervical, and certain brain tumors. The medicine is administered by intravenous infusion under the supervision of a healthcare professional.

BUY NOW

Category

Bevacizumab works by blocking vascular endothelial growth factor (VEGF), which helps reduce the formation of new blood vessels that supply tumors. It is commonly used in combination with other anticancer medicines according to the specific cancer and treatment protocol. Blood pressure, urine protein, bleeding, and wound healing may require monitoring during treatment. The dosage and treatment schedule are individualized by the treating oncologist based on the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg
Concentration 25 mg/mL
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial, 16 mL

Product Also Known As

Abevmy 400 mg Injection, Abevmy 400mg Injection, Abevmy 400 mg Vial, Abevmy 400mg Vial, Bevacizumab 400 mg Injection, Bevacizumab 400mg Injection, Bevacizumab 400 mg Vial